Home>By Brand>Xenosys
Repel-CV® REPEL-CV® Bioresorbable Adhesion Barrier reduces the incidence, extent and severity of post-operative cardiac adhesions. In a randomized, controlled, clinical trial conducted at 15 pediatric cardiothoracic surgery centers, REPEL-CV Bioresorbable Adhesion…
Brand: SyntheMed

By Brand

Vscan homepage

Vscan homepage

AED Homepage

AED-homepage-link

NEW! 2013-04-23 DoCOM Courses

DoCOM-Poster-JY20130423